PTP inhibitor 1 structure
|
Common Name | PTP inhibitor 1 | ||
|---|---|---|---|---|
| CAS Number | 2632-13-5 | Molecular Weight | 229.071 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 306.7±17.0 °C at 760 mmHg | |
| Molecular Formula | C9H9BrO2 | Melting Point | 69-71 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 139.3±20.9 °C | |
| Symbol |
GHS05, GHS07 |
Signal Word | Danger | |
Use of PTP inhibitor 1PTP inhibitor 1 is a protein tyrosine phosphatase (PTP) inhibitor, with anti-angiogenic effect[1]. |
| Name | 2-bromo-1-(4-methoxyphenyl)ethanone |
|---|---|
| Synonym | More Synonyms |
| Description | PTP inhibitor 1 is a protein tyrosine phosphatase (PTP) inhibitor, with anti-angiogenic effect[1]. |
|---|---|
| Related Catalog | |
| Target |
PTP[1] |
| In Vitro | PTP inhibitor 1 exhibits anti-angiogenic activity with an IC50 of 3.7 μM for HUVECs[1]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 306.7±17.0 °C at 760 mmHg |
| Melting Point | 69-71 °C(lit.) |
| Molecular Formula | C9H9BrO2 |
| Molecular Weight | 229.071 |
| Flash Point | 139.3±20.9 °C |
| Exact Mass | 227.978592 |
| PSA | 26.30000 |
| LogP | 2.27 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.554 |
| Storage condition | 2-8°C |
| Symbol |
GHS05, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H314-H335 |
| Precautionary Statements | P261-P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | Xi:Irritant |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S27-S28-S36/37/39-S45-S37/39 |
| RIDADR | UN 3261 8/PG 2 |
| WGK Germany | 3 |
| Packaging Group | III |
| Hazard Class | 8 |
| HS Code | 29147090 |
| Precursor 9 | |
|---|---|
| DownStream 10 | |
| HS Code | 2914700090 |
|---|---|
| Summary | HS: 2914700090 halogenated, sulphonated, nitrated or nitrosated derivatives of ketones and quinones, whether or not with other oxygen function Tax rebate rate:9.0% Supervision conditions:none VAT:17.0% MFN tariff:5.5% General tariff:30.0% |
|
Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.
J. Med. Chem. 54 , 4042-56, (2011) Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, bein... |
|
|
QSAR study and conformational analysis of 4-arylthiazolylhydrazones derived from 1-indanones with anti-Trypanosoma cruzi activity.
Eur. J. Pharm. Sci. 78 , 190-7, (2015) A set of 4-arylthiazolylhydrazones derived from 1-indanones (TZHs) previously synthesized and assayed against Trypanosoma cruzi, the causative agent of Chagas disease, were explored in terms of confor... |
|
|
Synthesis of diblock copolymers bearing p-methoxyphenacyl side groups.
Polym. Chem. 2(10) , 2284-2292, (2011)
|
| α-Bromo-4'-methoxyacetophenone |
| p-methoxyphenacyl bromide |
| 4'-Methoxyphenacyl Bromide |
| 4-Methoxyphenacyl Br |
| ω-Bromo-4-methoxyacetophenone |
| 2-Bromo-1-(4-methoxyphenyl)ethanone |
| 4-Methoxyphenacyl bromide |
| 2-Bromo-4′-methoxyacetophenone |
| 2-Bromo-4‘-methoxyacetophenone |
| Acetophenone, 2-bromo-4'-methoxy- |
| 2-Bromo-4'-methoxyacetophenone |
| MFCD00465443 |
| 2-bromo-1-(4'-methoxy-phenyl)-ethanone |
| 2-Bromo-4'-methoxyacetophenone, Pract. |
| Ethanone,2-bromo-1-(4-methoxyphenyl) |
| 1-(4-methoxyphenyl)-2-bromo-ethan-1-one |
| Ethanone, 2-bromo-1-(4-methoxyphenyl)- |
| EINECS 220-118-8 |
| 4-(Bromoacetyl)anisole |